Fulgent Genetics agrees to buy StrataDx and assets from Bako Diagnostics for $55.5 million. Learn how this cash deal expands ...
El Monte-based lab testing and pharmaceutical company Fulgent Genetics Inc. last month simultaneously announced a pair of ...
Fulgent’s arsenal has expanded to include a monkeypox test. Just as its record testing run for Covid-19 appears to be tapering off, Temple City-based Fulgent Genetics Inc. has added testing for ...
Fulgent Genetics is transitioning from a diagnostic business to a fully integrated healthcare company, with a focus on oncology. Despite past reliance on COVID-19 test revenues, Fulgent's core ...
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a ...
Ultra strong balance sheet that has a liquid asset balance almost equivalent to its current market capitalization. Profitable core laboratory testing business even without the temporary COVID-19 ...
In the most recent quarter, Fulgent's revenue grew to $126 million, a 124% increase over the third quarter of 2020. Taking a look at previous quarters, the overall revenue results for the company have ...
TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics”, “Fulgent”, or the “Company”), a technology-based genetic ...
Fulgent Genetics aims to transform from a genomic diagnostic business into a fully integrated precision medicine company focused on oncology Fulgent Pharma’s proprietary novel nano-drug delivery ...
LOS ANGELES (CBSLA) – The Los Angeles County Sheriff's Department will no longer use the COVID-19 testing provider Fulgent over its purported ties to the Chinese government, the Los Angeles Times ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback